Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Kumar RP, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Brieger DV, MakK.H, Kotlke-Marchant K, Topol EJ (1998) Heparin Induced thrombocytopenia. Am Coll Cardiol 31: 1449-1459.
Aouifi A, Blanc P, Pinou V, Bastien OH, Ffrench P, et al. (2001) Cardiac surgery with cardiopulmonary bypass in patients with type II heparin induced thrombocytopenia. Ann Thorac Surg 71: 678-683. Link: https://bit.ly/3nUOndd
Furukawa K, Ohteki H, Hirakata K, Narita Y, Koga S (2001) The use of Argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovas Surg 122: 1255-1256. Link: https://bit.ly/3pXu5kP
Merry AF, Raudkivi PJ, Middleton NG, Dougall MMCJ, Nanad P, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surgery 77: 925-931. Link: https://bit.ly/3l0LIgb
Kumar PR, Nazer YA (2018) New Dynamic Indian Correction for Mitral Valve repairs- non resectional neochordal graded reconstruction. Asian Annals of Cardiac Surgery.
Pradeep Kumar R, Nazer YA (2018) Video technique on New Dynamic Indian Correction for mitral valve repair. submitted to CTS net video session.
Pradeep Kumar R, Rajakumar, Murugan, Nazer YA (2018) Total Arterial Revascularization: Bypassing Antediluvian Notions. EC cardiology 4: 167-169. Link: https://bit.ly/3l3Is3w
Koster A, Spiess B, Chew DP, Krabatsch T, Tambeur L, et al. (2004) Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 93: 356-359. Link: https://bit.ly/2KCcAXh
Zucker ML, Koster A, Prats J, Laduca FM (2002) Sensitivity of a modified ACT Test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Tech 37: 364-368. Link: https://bit.ly/2HtkFw7
Dyke CM, Smedira NG, Koster AA, Aroson S, Mc carthy CCP, et al. (2006) Comparison of Bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The Evolution On study. J Thorac Cardiovas Surg 131: 5339. Link: https://bit.ly/39dPMY2
Stratmann G, de Silva AM, Tseng EE, Julie H, Michel B, et al. (2004) Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin induced thrombocytopenia. .Anaesth Anlag 98:1635-1639. Link: https://bit.ly/360q86Y
Pishko AM, Cuker A (2017) Heparin-induced thrombocytopenia in cardiac surgery patients. Semin Thromb Hemost. 43: 691-698. Link: https://bit.ly/2KBI7so
Hassen K, Maccaroni MR, Sabry H, Mukherjee S, Serumadar S, et al. (2018) Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation. Perfusion 33: 235-240. Link: https://bit.ly/3m0JI8Z
Seelhammer TG, Rowse P, Yalamuri S (2020) Bivalirudin for Maintenance Anticoagulation during Venovenous Extracorporeal Membrane Oxygenation for COVID -19. J Cardiothoracic Vasc Anesth. Link: https://bit.ly/39nJsxt
Rimans J, Sylvester KW, Connors JM (2017) Direct Thrombin inhibitor for LVAD thrombosis A Closer Look Clinc Apl Throm Hemost 23: 405-409. Link: https://bit.ly/363AymJ